Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marvell Technology Inc (MRVL) vs Morgan Stanley (MS) Price & Performance

Marvell Technology IncTrade
Morgan StanleyTrade

Price performance (Past 24H)

Key statistics

Marvell Technology Inc vs Morgan Stanley — how do they compare? Marvell Technology Inc trades at $280.07 (market cap $255.84B), while Morgan Stanley trades at $187.8 (market cap $297.95B). The key difference: Morgan Stanley is the larger of the two by market cap, and Morgan Stanley pays the higher dividend (2.42%). Which is the better fit depends on your goals — on Pluang, investors hold Marvell Technology Inc for 42 Days and Morgan Stanley for 93 Days on average.

MRVLMS
Market Cap
$255.84B$297.95B
Volume
23,652,5005,030,247
Sector
TechnologyFinancials
52-Week High
$316.43$228.42
52-Week Low
$73.73$151.86
Typical Hold Time
42 Days93 Days
Enterprise Value
$257.20B$663.67B
Dividend Yield
0.08%2.42%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marvell Technology Inc

Marvell Technology (MRVL) trades at $274.66, down 4.3% over 24 hours, amid strong bullish technical signals and robust analyst sentiment. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at 1.1. Revenue growth accelerated to 42% in fiscal 2026, driven by data center demand, while profitability metrics like a 52.21% gross margin underscore operational strength. Recent news highlights major custom AI chip deals, including a potential $120 billion agreement with Google.

Outlook remains positive given elevated AI infrastructure spending and raised fiscal 2028 revenue guidance to $18 billion. Risks include high valuation multiples (P/E of 94.26) and dependence on hyperscaler demand. With 84% analyst buy ratings and a $327.86 consensus target, the stock offers growth potential but requires monitoring of competitive and execution risks.

Morgan Stanley

Morgan Stanley (MS) trades at $187.41, down 1.86% on the day, with a bearish technical signal but strong fundamentals including a P/E of 15.32 and net income margin of 27.59%. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth is robust, rising from $50.2B in 2022 to $66.0B in 2025, and the company highlights growth opportunities in wealth management and AI financing.

The outlook is supported by a bullish analyst consensus with a $229.25 price target, though risks include volatile cash flows and rising debt-to-asset ratios. Near-term price action is testing support near $184, with investor sentiment mixed amid fading capital markets momentum but positive long-term growth narratives.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MRVL
56% Buy44% Sell
Avg holding period · 42 Days
MS
100% Buy0% Sell
Avg holding period · 93 Days

Top news

Latest headlines on both assets

About Marvell Technology Inc

Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.

Read more on MRVL →

About Morgan Stanley

Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.

Read more on MS →